Is Archer-Daniels-Midland (NYSE:ADM) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Archer-Daniels-Midland at current levels.
ADM's earnings trough is priced in at 14x forward earnings while the agricultural cycle quietly turns and the Nutrition segment finally inflects.
Where ADM is headed
Here's the absurdity: ADM is trading at 30x trailing earnings because it just printed one of its worst profit years in a decade — crushed margins in Ag Services, a Nutrition segment still digesting integration costs, and the accounting restatement hangover that obliterated investor trust in 2024. But flip to the forward P/E and you're paying 13.8x for a company analysts expect to grow earnings 16% next year. That gap between trailing and forward multiples is the entire thesis in one number. The market is staring in the rearview mirror at a trough, not through the windshield at recovery.
Read the full Compass Direction on ADM
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $80.12).
See the full ADM analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Archer-Daniels-Midland (NYSE:ADM) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Archer-Daniels-Midland at current levels. ADM's earnings trough is priced in at 14x forward earnings while the agricultural cycle quietly turns and the Nutrition segment finally inflects.
What is ADM's Compass Score?
Archer-Daniels-Midland scores 84/100 on Alexandria's Compass, placing it in the "True North" tier. Scores blend eight factors and update weekly.
What is the price target for ADM?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the ADM page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.